Pharma-Bio Serv (OTCMKTS:PBSV – Get Free Report) released its earnings results on Monday. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.04), Yahoo Finance reports. Pharma-Bio Serv had a negative return on equity of 0.04% and a negative net margin of 0.05%. The company had revenue of $2.42 million during the quarter, compared to analysts’ expectations of $3.50 million.
Pharma-Bio Serv Trading Up 1.5 %
PBSV traded up $0.01 on Wednesday, hitting $0.64. 1,107 shares of the stock traded hands, compared to its average volume of 4,339. Pharma-Bio Serv has a 52 week low of $0.52 and a 52 week high of $1.09. The business has a fifty day moving average price of $0.62 and a two-hundred day moving average price of $0.69.
About Pharma-Bio Serv
Further Reading
- Five stocks we like better than Pharma-Bio Serv
- Which Wall Street Analysts are the Most Accurate?
- This Is the Top Large-Cap Stock Insiders Are Buying
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Stocks to Take Advantage of Rising Gold Prices
Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.